Here are the local and international drugmakers also eyeing the Indian market and looking to introduce rivals to Lilly's drug ...

AM(IST)on Tuesday in an upbeat market. Abbott India Ltd.(up 0.74 per cent), Gland Pharma Ltd.(up 0.68 per cent), Biocon ...

ET Intelligence Group: The stock of Aurobindo Pharma has lost 13% in 2025 so far, underperforming the 10% drop in the BSE ...

Telangana: Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has received an Establishment ...

SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and ...

Curateq Biologics, a wholly owned subsidiary of Aurobindo Pharma, has allotted 4,125,055 Compulsory Convertible Preference Shares (CCPSs) of Rs.10/- each to Dr. Satakarni Makkapati on 20 March 2025.

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

Aurobindo Pharma rose 1.82% to Rs 1,157.90 after its subsidiary, Apitoria Pharma, received an establishment inspection report (EIR) from the U.S. Food and Drug Administration for its active ...

Indian banks such as SBI and ICICI have branches in Shanghai. ICBC started banking operations in India, and Bank of China ...

The first of the three vaccines is Covaxin, developed jointly by ICMR and Bharat Biotech, a private company. The government ...

Experts underestimated Trump's seriousness on tariffs; Indian auto and pharma sectors brace for impact, while steel remains ...

Aurobindo Pharma has terminated its licensing agreement with Hilleman Laboratories Singapore for a paediatric pentavalent vaccine candidate, effective March 5, 2025. The company clarifies that the ...